{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:24:40Z","timestamp":1790979880180,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ejogrb.2004.01.033","type":"journal-article","created":{"date-parts":[[2004,6,3]],"date-time":"2004-06-03T08:31:05Z","timestamp":1086251465000},"page":"S44-S56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"S","title":["GnRH antagonists"],"prefix":"10.1016","volume":"115","author":[{"given":"Maria Elisabetta","family":"Coccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Comparetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Bracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6655","key":"10.1016\/j.ejogrb.2004.01.033_BIB1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.01.033_BIB2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertil Steril"},{"issue":"3 Suppl","key":"10.1016\/j.ejogrb.2004.01.033_BIB3","first-page":"245","article-title":"GnRH agonists and in vitro fertilization","volume":"43","author":"Barlow","year":"1998","journal-title":"J Reprod Med"},{"issue":"23","key":"10.1016\/j.ejogrb.2004.01.033_BIB4","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1016\/S0021-9258(19)45877-8","article-title":"Isolation of the luteinizing hormone and follicle-stimulating hormone-releasing hormone from porcine hypothalami","volume":"246","author":"Schally","year":"1971","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB5","unstructured":"Committee for Proprietary Medicinal Products European Public Assessment Report (EPAR). Cetrotide. The European Agency for the Evaluation of Medicinal Products, 13 April 1999 CPMP\/2979\/98."},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1530\/eje.0.1310286","article-title":"Inhibition of luteinising hormone, follicle-stimulating hormone, and sex-steroid levels in men and women with a potent antagonist analogue of luteinising hormone-releasing hormone, cetrorelix SB-75","volume":"131","author":"Gonzalez-Barcena","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB7","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/humrep\/13.9.2392","article-title":"Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist cetrorelix in healthy female volunteers","volume":"13","author":"Duijkers","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1530\/eje.0.1310280","article-title":"Seven day administration of the gonadotrophin-releasing hormone antagonist cetrorelix in normal cycling women","volume":"131","author":"Sommer","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(16)56932-5","article-title":"A single injection of gonadotrophin-releasing hormone GnRH antagonist cetrorelix postpones the luteinising hormone LH surge: further evidence for the role of GnRH during the LH surge","volume":"62","author":"Leroy","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0301-2115(95)02138-W","article-title":"Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonist cetrorelix in women with tubal infertility","volume":"61","author":"Felberbaum","year":"1995","journal-title":"Eur J Obstet Gynaecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.01.033_BIB11","first-page":"342","article-title":"Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys","volume":"84","author":"Duffy","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(98)00135-6","article-title":"The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotrophin and the gonadotrophin-releasing hormone antagonist cetrorelix","volume":"70","author":"Albano","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/humrep\/14.4.885","article-title":"Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilisation either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?","volume":"14","author":"Lin","year":"1999","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.01.033_BIB14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(16)57531-1","article-title":"Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)","volume":"63","author":"Nelson","year":"1995","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.01.033_BIB15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.301.1.95","article-title":"Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix","volume":"301","author":"Broqua","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB16","unstructured":"Royal College of Obstetricians and Gynaecologists. The management of infertility in tertiary care, UK, Evidence-Based Clinical Guideline 2000;6."},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000271829","article-title":"Gonadotropin releasing hormone and analogs. Physiology and pharmacology","volume":"32","author":"Kiesel","year":"1992","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB18","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/oxfordjournals.humrep.a136219","article-title":"Development and applications of luteinising hormone-releasing hormone antagonists in the treatment of infertility: an overview","volume":"10","author":"Reissmann","year":"1995","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.ejogrb.2004.01.033_BIB19","first-page":"370","article-title":"Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders","volume":"144","author":"Fauser","year":"2000","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.01.033_BIB20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mcp.2000.111481","article-title":"Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women","volume":"68","author":"Nagaraja","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.01.033_BIB21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(99)00413-6","article-title":"Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon\/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers","volume":"72","author":"Oberye","year":"1999","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.01.033_BIB22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(99)00414-8","article-title":"Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon\/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers","volume":"72","author":"Oberye","year":"1999","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2004.01.033_BIB23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000272579","article-title":"GnRH antagonists in gynecology: initial results within the scope of controlled ovarian hyperstimulation","volume":"35","author":"Felberbaum","year":"1995","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB24","first-page":"1382","article-title":"Scheduled administration of a gonadotrophin-releasing hormone antagonist cetrorelix on day 8 of in-vitro fertilization cycles: a pilot study","volume":"10","author":"Olivennes","year":"1995","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.01.033_BIB25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(16)57531-1","article-title":"Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)","volume":"63","author":"Nelson","year":"1995","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.01.033_BIB26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0015-0282(16)58404-0","article-title":"Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist","volume":"66","author":"Olivennes","year":"1996","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.ejogrb.2004.01.033_BIB27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/oxfordjournals.humrep.a019409","article-title":"Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles","volume":"11","author":"Ubaldi","year":"1996","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/13.3.573","article-title":"High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in vitro fertilization","volume":"13","author":"de Jong","year":"1998","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.01.033_BIB29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/13.2.294","article-title":"First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)","volume":"13","author":"Itskovitz-Eldor","year":"1998","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0015-0282(16)56594-7","article-title":"Successful pregnancies with unstimulated cycle oocyte donation using an antagonist of gonadotropin-releasing hormone","volume":"61","author":"Meldrum","year":"1994","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.01.033_BIB31","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/humrep\/14.10.2665","article-title":"Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction\/in-vitro fertilization prior to cancer treatment","volume":"14","author":"Anderson","year":"1999","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0015-0282(01)03008-4","article-title":"Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle","volume":"77","author":"Seelig","year":"2002","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.01.033_BIB33","first-page":"253","article-title":"GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome","volume":"47","author":"Chang","year":"2002","journal-title":"J Reprod Med"},{"issue":"8","key":"10.1016\/j.ejogrb.2004.01.033_BIB34","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/17.8.2022","article-title":"Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to \u201cfriendly IVF\u201d?","volume":"17","author":"Engel","year":"2002","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.01.033_BIB35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0950-3552(98)80055-2","article-title":"The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease","volume":"12","author":"Lubin","year":"1998","journal-title":"Baillieres Clin Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.ejogrb.2004.01.033_BIB36","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/16.8.1588","article-title":"Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report","volume":"16","author":"Olivennes","year":"2001","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.01.033_BIB37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/humupd\/6.4.318","article-title":"Induction of ovulation after gnRH antagonists","volume":"6","author":"Ron-El","year":"2000","journal-title":"Hum Reprod Update"},{"issue":"9","key":"10.1016\/j.ejogrb.2004.01.033_BIB38","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.01.033_BIB39","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/humrep\/14.12.2959","article-title":"Will GnRH antagonists provide new hope for patients considered \u2018difficult responders\u2019 to GnRH agonist protocols?","volume":"14","author":"Craft","year":"1999","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ejogrb.2004.01.033_BIB40","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/humrep\/15.10.2145","article-title":"Addition of GnRH antagonist in cycles of poor responders undergoing IVF","volume":"15","author":"Akman","year":"2000","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ejogrb.2004.01.033_BIB41","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/humrep\/16.12.2570","article-title":"Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone","volume":"16","author":"Behre","year":"2001","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.01.033_BIB42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/humupd\/6.4.322","article-title":"The LHRH antagonist cetrorelix: a review","volume":"6","author":"Reissmann","year":"2000","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00001703-200106000-00002","article-title":"Gonadotropin-releasing hormone antagonist: how good is the new hope?","volume":"13","author":"Albano","year":"2001","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1258\/0007142001903346","article-title":"Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications","volume":"56","author":"Millar","year":"2000","journal-title":"Br Med Bull"},{"issue":"2 Pt 2","key":"10.1016\/j.ejogrb.2004.01.033_BIB45","first-page":"1S25","article-title":"LH and GnRH antagonists","volume":"31","author":"Olivennes","year":"2002","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.01.033_BIB46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humrep\/14.suppl_1.207","article-title":"Ovarian stimulation for in-vitro fertilization\/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists","volume":"14","author":"Felberbaum","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2001.tb03789.x","article-title":"Gonadotropin-releasing hormone antagonists implications for oocyte quality and uterine receptivity","volume":"943","author":"Gordon","year":"2001","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2001-18040","article-title":"The role of gonadotropin-releasing hormone antagonists in in vitro fertilization","volume":"19","author":"Diedrich","year":"2001","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.01.033_BIB49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003495-200059010-00007","volume":"59","author":"Gillies","year":"2000","journal-title":"Ganirelix Drugs"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.01.033_BIB50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0301-2115(99)00195-5","article-title":"No significant leukocytosis under controlled ovarian stimulation using the LHRH antagonist Cetrorelix and recFSH","volume":"89","author":"Ludwig","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.ejogrb.2004.01.033_BIB51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/6.5.505","article-title":"Direct ovarian effects and safety aspects of GnRH agonists and antagonists","volume":"6","author":"Hanssens","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0301-2115(95)02138-W","article-title":"Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonist cetrorelix in women with tubal infertility","volume":"61","author":"Felberbaum","year":"1995","journal-title":"Eur J Obstet Gynaecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB53","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/oxfordjournals.humrep.a019058","article-title":"Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausagonadotrophin and gonadotrophin-releasing hormone antagonist cetrorelix","volume":"11","author":"Albano","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB54","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinising hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB55","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotrophin-releasing hormone antagonist cetrorelix in an in vitro fertilization\u2014embryo transfer programme","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB56","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/13.9.2411","article-title":"The use of a GnRH antagonist Cetrorelix in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 mg versus 2 mg","volume":"13","author":"Olivennes","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotrophin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation","volume":"65","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB58","doi-asserted-by":"crossref","unstructured":"The Ganirelix Dose-Finding Study Group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod 1998;13,(11):3023-31.","DOI":"10.1093\/humrep\/13.11.3023"},{"issue":"6","key":"10.1016\/j.ejogrb.2004.01.033_BIB59","first-page":"721","article-title":"Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation","volume":"52","author":"Christin-Maitre","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone LHRH-antagonist cetrorelix and the LHRH-agonist buserelin","volume":"153","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2004.01.033_BIB61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2004.01.033_BIB62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.01.033_BIB63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","article-title":"Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis","volume":"265","author":"Ludwig","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2004.01.033_BIB64","doi-asserted-by":"crossref","unstructured":"Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2001;(4):CD001750.","DOI":"10.1002\/14651858.CD001750"},{"issue":"4","key":"10.1016\/j.ejogrb.2004.01.033_BIB65","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"issue":"7 Part 1","key":"10.1016\/j.ejogrb.2004.01.033_BIB66","first-page":"657","article-title":"GnRH antagonists in IVF","volume":"30","author":"Olivennes","year":"2001","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"3","key":"10.1016\/j.ejogrb.2004.01.033_BIB67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/humupd\/8.3.279","article-title":"The use of GnRH antagonists in ovarian stimulation","volume":"8","author":"Olivennes","year":"2002","journal-title":"Hum Reprod Update"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:11:03Z","timestamp":1759554663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":67,"alternative-id":["S0301211504000181"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.01.033","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GnRH antagonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}